Radiofrequency ablation compared to resection in early-stage hepatocellular carcinoma
β Scribed by Samer Tohme; David A. Geller; Jon S. Cardinal; Hui-Wei Chen; Vignesh Packiam; Srinevas Reddy; Jennifer Steel; James W. Marsh; Allan Tsung
- Book ID
- 117960255
- Publisher
- John Wiley and Sons
- Year
- 2013
- Tongue
- English
- Weight
- 539 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1365-182X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
No adequate randomized trials have been reported for a comparison between hepatic resection (HR) versus radiofrequency ablation (RFA) for the treatment of patients with very early stage hepatocellular carcinoma (HCC), defined as an asymptomatic solitary HCC <2 cm. For compensated cirrhotic patients
## Abstract ## BACKGROUND: Radiofrequency ablation (RFA) is becoming a wellβknown local therapy for hepatocellular carcinoma (HCC). Transcatheter arterial chemoembolization (TACE) is expected to enhance the effects of subsequent RFA by reducing arterial blood flow. However, the longβterm efficacy